NEW YORK (GenomeWeb News) – Bulgaria has installed a new IBM Blue Gene/P supercomputer, which it plans to use for genomics, proteomics, and drug studies, as well as for other purposes such as financial modeling, at the Bulgarian State Agency for Information Technology in Sofia.
The Bulgarian National Centre for Human Genomics and Proteomics will use the Blue Gene/P to run algorithms to isolate key genes and drug targets in common diseases. Researchers plan to analyze the function of population-validated disease genes and the proteins they encode in studies of biological pathways of diseases.
Bulgaria also will use the computer to simulate drug development and to filter through sequencing data from the human genome.
"This agreement with IBM begins a new era of supercomputing in Bulgaria and creates huge potential to boost scientific research in the region as a whole," Plamen Vachkov, chairman of the Bulgarian State Agency for Information Technology and Communications, said in a statement.